Fast-food restaurants are revamping their menus to attract customers using GLP-1 weight-loss medications. Chains like McDonald's, Shake Shack, and Chipotle are introducing healthier, high-protein options to meet the evolving dietary preferences of these consumers, who are increa…
Recent developments in weight-loss medications highlight the potential of amylin-based drugs, which may offer effective weight management with fewer gastrointestinal side effects…
A recent study published in the journal Childhood Obesity reveals that approximately 16.8% of children aged 10 to 17 who began treatment with GLP-1 receptor agonist medications de…
Research into GLP-1 medications, such as Ozempic and Wegovy, indicates they may play a role in reducing cancer risk by improving metabolic health, but the evidence remains mixed a…
Numerous lawsuits have been initiated in the United States against companies producing GLP-1 medications, such as Ozempic and Mounjaro, claiming these drugs may lead to a rare eye…
As GLP-1 medications gain popularity for weight loss, their use among college women during sorority recruitment raises concerns about body image pressures. A recent analysis indic…
A recent review in JAMA Otolaryngology highlights the potential benefits of GLP-1 weight-loss drugs, such as tirzepatide, in reducing the severity of obesity-related sleep apnea.…
At the Socialism 2026 conference in Chicago, activist Da’Shaun L. Harrison criticized the diet industry for its policing of 'Black fat flesh,' labeling modern health standards as…
Recent research indicates that GLP-1 weight-loss drugs, such as semaglutide, may not only aid in weight management but also extend lifespan in older female mice. The study found t…
A recent examination reveals a troubling connection between school absence and childhood obesity in the UK. Many children treated for severe obesity at specialist clinics have not…
Eli Lilly has reported a significant revenue increase of 47% in the second quarter, reaching $22.97 billion, despite a decline in employer insurance coverage for GLP-1 weight-loss…
As the popularity of weight-loss drugs like GLP-1 receptor agonists grows, a black market for the unapproved drug retatrutide has emerged, alarming health experts. Developed by El…
In a bold move to align with modern wellness trends, L'Oreal is developing skincare products specifically designed for users of weight-loss drugs, navigating the turbulent waters…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
The Federal Reserve's latest Beige Book indicates a modest increase in US economic activity, slight employment growth, and moderate price increases. The report highlights mixed se…